一名年轻孕妇致命性围产期心肌病的成功管理：病例报告
Successful management of fatal peripartum cardiomyopathy in a young pregnant woman: A case report.
作者信息
Huang Yaqing, Chen Tianqi, Zhang Meiqi, Yang Xianghong, Ding Guodong, Yang Liwei
机构信息
Department of Obstetrics, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College The Second Clinical Medical College, Zhejiang Chinese Medical University Department of Emergency, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College Department of Intensive Care Unit, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College Department of Anesthesia, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
出版信息
Medicine (Baltimore). 2018 Apr;97(15):e0408. doi: 10.1097/MD.0000000000010408.
RATIONALE
Peripartum cardiomyopathy (PPCM) is a rare and life-threatening form of pregnancy associated myocardial disease.
PATIENT CONCERNS
In the present report, we describe a case of a patient with PPCM at 33 weeks of gestation with stillbirth and cardiorespiratory failure.
DIAGNOSES
Peripartum cardiomyopathy.
INTERVENTIONS
The patient underwent emergency cesarean section (CS) and comprehensive medical treatments, including bromocriptine, as well as positive inotropic agents and diuretics after the CS.
OUTCOMES
She had an uneventful recovery period, and was discharged 9 days after surgery. Her heart function was restored within 6 months after CS, and follow-up echocardiographies indicated normal heart function.
LESSONS
This case highlights that early diagnosis and timely termination of pregnancy are crucial in the management of PPCM.
理论依据
围产期心肌病（PPCM）是一种罕见且危及生命的妊娠相关心肌疾病。
患者情况
在本报告中，我们描述了一例妊娠33周时患有围产期心肌病的患者，出现死产和心肺功能衰竭。
诊断
围产期心肌病。
干预措施
患者接受了急诊剖宫产（CS）及综合药物治疗，包括溴隐亭，剖宫产术后还使用了正性肌力药物和利尿剂。
结果
她恢复过程顺利，术后9天出院。剖宫产术后6个月内心脏功能恢复，后续超声心动图检查显示心脏功能正常。
经验教训
该病例强调早期诊断和及时终止妊娠在围产期心肌病管理中至关重要。
Zotero 插件